The platform will undergo maintenance on Sep 14 at about 9:30 AM EST and will be unavailable for approximately 1 hour.
2018
DOI: 10.1088/2053-1591/aae11b
|View full text |Cite
|
Sign up to set email alerts
|

Development of a novel nano-biomaterial for biomedical applications

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
2

Relationship

1
1

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 75 publications
0
2
0
Order By: Relevance
“…In cancer therapy, the major difficulty is to destroy tumor cells without harming the surrounding normal tissues. One of the ways to get around this problem is protecting magnetic nanoparticles (MNPs) with polymeric coatings to prevent their agglomeration while conferring to the nanocomposite system drug release capabilities [ 1 ]. On the other hand, MNPs can ensure the mobility of the polymeric nanoparticles when a magnetic field is applied, enabling their use for drug release and for treatment by hyperthermia.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…In cancer therapy, the major difficulty is to destroy tumor cells without harming the surrounding normal tissues. One of the ways to get around this problem is protecting magnetic nanoparticles (MNPs) with polymeric coatings to prevent their agglomeration while conferring to the nanocomposite system drug release capabilities [ 1 ]. On the other hand, MNPs can ensure the mobility of the polymeric nanoparticles when a magnetic field is applied, enabling their use for drug release and for treatment by hyperthermia.…”
Section: Introductionmentioning
confidence: 99%
“…Therefore, considering the biocompatibility and bioreabsorbability of poly(L-co-D,L acid lactic-co-trimethylene carbonate (PLDLA-co-TMC) and of poly(ethylene oxide)–poly(propylene oxide)–poly(ethylene oxide) (PEO–PPO–PEO), our research group has reported on the preparation of PLDLA-co-TMC/PEO–PPO–PEO-based nanocomposites incorporating the finasteride drug prepared through the SDM method. Such a composite revealed to be promising as a drug delivery system [ 1 ]. On the other hand, hybrid nanoparticles consisting of MNP cores and PLDLA-co-TMC and PEO–PPO–PEO triblock copolymer shells in different ratios were recently investigated [ 13 , 14 ].…”
Section: Introductionmentioning
confidence: 99%